These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mechanisms of vascular disease in hypertension with special reference to diabetes. Yudkin JS Semin Vasc Med; 2002 May; 2(2):139-48. PubMed ID: 16222605 [TBL] [Abstract][Full Text] [Related]
3. [Trends in subclinical atherosclerosis in patients with arterial hypertension associated with diabetes mellitus: a relationship between blood pressure achieved with antihypertensive therapy and body weight]. Karpov RS; Koshel'skaia OA; Khoroshilova IV Ter Arkh; 2010; 82(9):23-30. PubMed ID: 21086616 [TBL] [Abstract][Full Text] [Related]
4. [Pathophysiological conditions progressing from impaired glucose tolerance: high blood pressure]. Katayama S Nihon Rinsho; 2005 Feb; 63 Suppl 2():242-5. PubMed ID: 15779379 [No Abstract] [Full Text] [Related]
5. Quinapril reduces arterial blood pressure and improves metabolic control in elderly hypertensive diabetic patients. Paolisso G; Gambardella A; Verza M; Varricchio M Diabete Metab; 1990; 16(3):264-5. PubMed ID: 2210025 [No Abstract] [Full Text] [Related]
6. Benefits of strict glucose and blood pressure control in type 2 diabetes: lessons from the UK Prospective Diabetes Study. Laakso M Circulation; 1999 Feb; 99(4):461-2. PubMed ID: 9927388 [No Abstract] [Full Text] [Related]
8. [24 hours ambulatory blood pressure in impaired glucose tolerance patients]. Li C; Pan C; Lu J Zhonghua Nei Ke Za Zhi; 1997 Aug; 36(8):536-9. PubMed ID: 10436960 [TBL] [Abstract][Full Text] [Related]
9. Antihypertensive and metabolic effects of lacidipine in patients with NIDDM and/or hypertension. Galeone F; Giuntoli F; Fiore G; Brunelleschi G; Saba P J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S105-7. PubMed ID: 7609495 [TBL] [Abstract][Full Text] [Related]
11. Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance. Taniguchi A; Fukushima M; Sakai M; Nagata I; Doi K; Nagasaka S; Tokuyama K; Nakai Y Diabetes Care; 2000 Jan; 23(1):127-8. PubMed ID: 10857985 [No Abstract] [Full Text] [Related]
12. Type 2 diabetes mellitus and arterial hypertension: etiology and therapeutical approach. Brunetti P; Torlone E Contrib Nephrol; 1994; 106():157-61. PubMed ID: 8174364 [No Abstract] [Full Text] [Related]
13. Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus. Vuorinen-Markkola H; Yki-Järvinen H Metabolism; 1995 Jan; 44(1):85-9. PubMed ID: 7854171 [TBL] [Abstract][Full Text] [Related]
14. The goal blood pressure in type 2 diabetes: do we have an ACCORD? Crouch MA Consult Pharm; 2010 Oct; 25(10):686, 688. PubMed ID: 21030359 [No Abstract] [Full Text] [Related]
15. Clinical usefulness of doxazosin in patients with type 2 diabetes complicated by hypertension: effects on glucose and lipid metabolism. Inukai T; Inukai Y; Matsutomo R; Okumura K; Takanashi K; Takebayashi K; Tayama K; Aso Y; Takemura Y J Int Med Res; 2004; 32(2):206-13. PubMed ID: 15080025 [TBL] [Abstract][Full Text] [Related]
16. Strategies and goals for hypertension control in patients with diabetes mellitus. Kotchen TA Hypertension; 2010 Jul; 56(1):24-5. PubMed ID: 20497989 [No Abstract] [Full Text] [Related]
17. [Intensive control of arterial pressure prevents renal impairement in patients with diabetes mellitus]. Makolkin VI Kardiologiia; 2009; 49(2):91-5. PubMed ID: 19254227 [No Abstract] [Full Text] [Related]
18. Does impaired glucose tolerance predict hypertension? A prospective analysis. Vaccaro O; Imperatore G; Iovino V; Iovine C; Rivellese AA; Riccardi G Diabetologia; 1996 Jan; 39(1):70-6. PubMed ID: 8720605 [TBL] [Abstract][Full Text] [Related]
19. Diabetic nephropathy in non-insulin dependent diabetes mellitus. Cardiovascular risk factors and antihypertensive treatment. Nielsen FS Dan Med Bull; 2000 Sep; 47(4):249-70. PubMed ID: 11064829 [No Abstract] [Full Text] [Related]
20. [Effect of ACE gene polymorphism on carbohydrate metabolism, on oxidative stress and on end-organ damage in type-2 diabetes mellitus]. Molnár GA; Wagner Z; Wagner L; Melegh B; Kószegi T; Degrell P; Bene J; Tamaskó M; Laczy B; Nagy J; Wittmann I Orv Hetil; 2004 Apr; 145(16):855-9. PubMed ID: 15156690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]